RSS Feed
Search Ask-Cato.com
Tags
adverse events biologics biomarkers biosimilar biotech cancer Cato BioVentures Cato Research CDER clinical investigator clinical research clinical trials CMC conference CROs DIA drug development eCTD efficacy FDA funding GlobalSubmit guidance Health Canada IND in vitro diagnostics manufacturing marketing application medical devices NDA NIH nonclinical research oncology Phase 1 Phase 2 PMA postmarketing protocol safety statistical analysis toxicology transparency vaccines venture capital webinarCategories
- Clinical Trials (55)
- Conferences and Meetings (35)
- eCTD (26)
- FDA (78)
- Guest Posts (5)
- Health Canada (6)
- Industry News (62)
- Project Management (1)
- Publications (7)
- Regulatory Strategy (39)
- Social Media (6)
- Statistics (9)
- Uncategorized (1)
- Venture Capital (10)
- Webinars (24)
Tag Archives: vaccines
Cato at the Cancer Vaccines Meeting
This week, Cato Research is attending the Cancer Vaccines meeting in Cambridge, MA on 29 and 30 June. The conference is the first meeting dedicated to progressing cancer vaccines to market and will feature 21 of the world’s leading experts … Continue reading
Posted in Conferences and Meetings
Tagged cancer, Chemotherapy, clinical trials, immune system, monoclonal antibody therapy, pancreatic cancer, vaccines
Comments Off
Challenges associated with oncology development within an immunotherapeutic platform
Although cancer immunotherapeutics (intended to treat already existing cancers by strengthening the body’s natural defenses) represent a very active area of development world wide, few cancer immunotherapeutics have been approved to date. Unfortunately, the overall clinical benefit in patients treated … Continue reading
Posted in Clinical Trials
Tagged clinical trials, immunotherapeutics, oncology, personalized medicine, vaccines
Comments Off
